TSE:4929

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Adjuvant Cosme JapanLtd

Market Cap

JP¥8.3b

Last Updated

2021/06/18 08:02 UTC

Data Sources

Company Financials

Executive Summary

Adjuvant Cosme Japan Co.,Ltd. engages in the research, development, production, and sale of cosmetics in Japan. More Details


Snowflake Analysis

Flawless balance sheet and fair value.


Similar Companies

Share Price & News

How has Adjuvant Cosme JapanLtd's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 4929 is not significantly more volatile than the rest of JP stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 4929's weekly volatility (4%) has been stable over the past year.


Market Performance


7 Day Return

0.9%

4929

1.3%

JP Personal Products

0.4%

JP Market


1 Year Return

9.4%

4929

2.0%

JP Personal Products

22.6%

JP Market

Return vs Industry: 4929 exceeded the JP Personal Products industry which returned 2% over the past year.

Return vs Market: 4929 underperformed the JP Market which returned 22.6% over the past year.


Shareholder returns

4929IndustryMarket
7 Day0.9%1.3%0.4%
30 Day1.2%5.4%3.6%
90 Day-9.4%-0.7%-2.3%
1 Year11.7%9.4%3.3%2.0%25.3%22.6%
3 Year1.8%-5.2%-15.1%-18.2%20.3%12.1%
5 Year32.8%17.9%88.8%76.3%78.4%58.9%

Long-Term Price Volatility Vs. Market

How volatile is Adjuvant Cosme JapanLtd's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Adjuvant Cosme JapanLtd undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 4929 (¥1034) is trading below our estimate of fair value (¥3416.43)

Significantly Below Fair Value: 4929 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 4929 is poor value based on its PE Ratio (58.2x) compared to the JP Personal Products industry average (35.8x).

PE vs Market: 4929 is poor value based on its PE Ratio (58.2x) compared to the JP market (16.4x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 4929's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 4929 is good value based on its PB Ratio (2x) compared to the JP Personal Products industry average (3x).


Future Growth

How is Adjuvant Cosme JapanLtd forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

17.8%

Forecasted Household industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Adjuvant Cosme JapanLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Adjuvant Cosme JapanLtd performed over the past 5 years?

-49.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 4929 has a large one-off loss of ¥145.0M impacting its March 20 2021 financial results.

Growing Profit Margin: 4929 became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: 4929's earnings have declined by 49.4% per year over the past 5 years.

Accelerating Growth: 4929 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 4929 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Personal Products industry (-17.7%).


Return on Equity

High ROE: 4929's Return on Equity (3.5%) is considered low.


Financial Health

How is Adjuvant Cosme JapanLtd's financial position?


Financial Position Analysis

Short Term Liabilities: 4929's short term assets (¥2.7B) exceed its short term liabilities (¥547.0M).

Long Term Liabilities: 4929's short term assets (¥2.7B) exceed its long term liabilities (¥457.0M).


Debt to Equity History and Analysis

Debt Level: 4929 is debt free.

Reducing Debt: 4929 has no debt compared to 5 years ago when its debt to equity ratio was 0.05%.

Debt Coverage: 4929 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 4929 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Adjuvant Cosme JapanLtd current dividend yield, its reliability and sustainability?

2.32%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 4929's dividend (2.32%) is higher than the bottom 25% of dividend payers in the JP market (1.31%).

High Dividend: 4929's dividend (2.32%) is low compared to the top 25% of dividend payers in the JP market (2.99%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, 4929 has been paying a dividend for less than 10 years.

Growing Dividend: 4929's dividend payments have increased, but the company has only paid a dividend for 8 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (135%), 4929's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.6yrs

Average management tenure


CEO

Kenji Matsui (55 yo)

5yrs

Tenure

Mr. Kenji Matsui has been President and Representative Director of Adjuvant Cosme Japan Co.,Ltd. (a/k/a Adjuvant Kansai Hanbai) since June 16, 2016 and served as its Managing Director since June 2011 and s...


Leadership Team

Experienced Management: 4929's management team is seasoned and experienced (7.6 years average tenure).


Board Members

Experienced Board: 4929's board of directors are considered experienced (8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Adjuvant Cosme Japan Co.,Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Adjuvant Cosme Japan Co.,Ltd.
  • Ticker: 4929
  • Exchange: TSE
  • Founded: 1990
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: JP¥8.265b
  • Shares outstanding: 7.99m
  • Website: https://www.adjuvant.co.jp

Number of Employees


Location

  • Adjuvant Cosme Japan Co.,Ltd.
  • 5-5-5, Shimoyamate-dori
  • Chuo-ku
  • Kobe
  • Hyogo
  • 650-0011
  • Japan

Listings


Biography

Adjuvant Cosme Japan Co.,Ltd. engages in the research, development, production, and sale of cosmetics in Japan. The company offers skin care products, including cleansing products, face washes, lotions, be...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/18 08:02
End of Day Share Price2021/06/18 00:00
Earnings2021/03/20
Annual Earnings2021/03/20


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.